| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.097 | 0.05 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.09 | 0.05 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.05 |